Literature DB >> 10559610

Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group.

J H Blom1, H van Poppel, J M Marechal, D Jacqmin, R Sylvester, F H Schröder, L de Prijck.   

Abstract

OBJECTIVE: The authors present demographic and surgical data from a randomized phase III trial, instituted by the EORTC Genitourinary Group in 1988, the aim of which was to assess whether complete lymph node dissection in conjunction with radical nephrectomy for renal cell cancer is more effective than radical nephrectomy alone.
METHODS: Before surgery, the renal cell carcinoma was staged and judged to be nonmetastatic and resectable. The patients were randomized prior to surgery into those having radical nephrectomy combined with complete lymph node dissection or into those having radical nephrectomy alone. Postoperatively all patients were followed until progression of disease or death.
RESULTS: Of the 772 randomized patients, 41 were not eligible. 383 had a complete lymph node dissection together with a radical nephrectomy. 389 had a radical nephrectomy alone. The complication rate did not differ significantly between the two groups. A complete lymph node dissection in 336 patients revealed absence of lymph node metastases in 325 of them.
CONCLUSIONS: The present study shows that complete lymph node dissection does not add morbidity to the radical nephrectomy. After proper preoperative staging, the incidence of unsuspected lymph node metastases is low (3.3%). Copyright 1999 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  1999        PMID: 10559610     DOI: 10.1159/000020050

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  25 in total

Review 1.  [Lymph node dissection in patients with renal cell carcinoma].

Authors:  T Ebert; D Schnell; L Weissbach
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

2.  [Renal cell carcinoma].

Authors:  A Haferkamp; D Rohde; S C Müller; H Rübben; M Hohenfellner
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

3.  Locally advanced renal cell carcinoma.

Authors:  Mohammed Al Otaibi; Simon Tanguay
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

Review 4.  [Uro-oncology--update 2009].

Authors:  T Otto
Journal:  Urologe A       Date:  2009-09       Impact factor: 0.639

5.  Subclavian vein thrombosis: an unusual presentation of renal cell carcinoma.

Authors:  Ammar Hameed; Ajay Pahuja; Ali Thwaini; Thiagarajan Nambirajan
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

Review 6.  [Operative treatment of renal cell carcinoma].

Authors:  A Heidenreich
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

7.  Molecular aspects of renal cell carcinoma: a review.

Authors:  Hari Koul; Jung-Sik Huh; Kyle O Rove; Luiza Crompton; Sweaty Koul; Randall B Meacham; Fernando J Kim
Journal:  Am J Cancer Res       Date:  2010-12-18       Impact factor: 6.166

Review 8.  [Relevance of radiological imaging for lymph node surgery of urological tumors].

Authors:  J Stattaus; M Forsting
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

Review 9.  Adjuvant therapy for renal cell carcinoma.

Authors:  Naomi B Haas; Robert Uzzo
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

10.  Staging of renal cell carcinoma: Current concepts.

Authors:  John S Lam; Tobias Klatte; Alberto Breda
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.